Dermata Therapeutics Warrant Stock Gross Profit

DRMAW Stock  USD 0.02  0.00  0.000005%   
Dermata Therapeutics Warrant fundamentals help investors to digest information that contributes to Dermata Therapeutics' financial success or failures. It also enables traders to predict the movement of Dermata Stock. The fundamental analysis module provides a way to measure Dermata Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dermata Therapeutics stock.
Last ReportedProjected for Next Year
Gross Profit(370.30)(388.81)
Gross Profit is likely to drop to -388.81 in 2025.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Dermata Therapeutics Warrant Company Gross Profit Analysis

Dermata Therapeutics' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Current Dermata Therapeutics Gross Profit

    
  -388.81  
Most of Dermata Therapeutics' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dermata Therapeutics Warrant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Dermata Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for Dermata Therapeutics is extremely important. It helps to project a fair market value of Dermata Stock properly, considering its historical fundamentals such as Gross Profit. Since Dermata Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dermata Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dermata Therapeutics' interrelated accounts and indicators.
1.0-0.95-0.12-1.00.54-0.951.0-0.110.411.0-0.010.41-0.56-0.79-0.81-0.95
1.0-0.95-0.14-1.00.56-0.951.0-0.090.421.00.010.42-0.58-0.79-0.82-0.95
-0.95-0.950.120.93-0.441.0-0.950.11-0.31-0.950.01-0.310.530.750.741.0
-0.12-0.140.120.12-0.710.12-0.12-0.95-0.58-0.12-0.99-0.580.830.150.350.12
-1.0-1.00.930.12-0.550.93-1.00.11-0.42-1.00.01-0.420.560.790.810.93
0.540.56-0.44-0.71-0.55-0.440.540.520.590.540.630.59-0.84-0.66-0.85-0.44
-0.95-0.951.00.120.93-0.44-0.950.11-0.31-0.950.01-0.310.530.750.741.0
1.01.0-0.95-0.12-1.00.54-0.95-0.110.411.0-0.010.41-0.56-0.79-0.81-0.95
-0.11-0.090.11-0.950.110.520.11-0.110.61-0.110.970.61-0.720.06-0.140.11
0.410.42-0.31-0.58-0.420.59-0.310.410.610.410.541.0-0.83-0.34-0.58-0.31
1.01.0-0.95-0.12-1.00.54-0.951.0-0.110.41-0.010.41-0.56-0.79-0.81-0.95
-0.010.010.01-0.990.010.630.01-0.010.970.54-0.010.54-0.76-0.02-0.220.01
0.410.42-0.31-0.58-0.420.59-0.310.410.611.00.410.54-0.83-0.34-0.58-0.31
-0.56-0.580.530.830.56-0.840.53-0.56-0.72-0.83-0.56-0.76-0.830.460.710.53
-0.79-0.790.750.150.79-0.660.75-0.790.06-0.34-0.79-0.02-0.340.460.910.75
-0.81-0.820.740.350.81-0.850.74-0.81-0.14-0.58-0.81-0.22-0.580.710.910.74
-0.95-0.951.00.120.93-0.441.0-0.950.11-0.31-0.950.01-0.310.530.750.74
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition

Dermata Therapeutics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Dermata Therapeutics from analyzing Dermata Therapeutics' financial statements. These drivers represent accounts that assess Dermata Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Dermata Therapeutics' important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Enterprise Value651.4M206.6M61.6M(1.1M)(1.3M)(1.2M)

Dermata Fundamentals

About Dermata Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Dermata Therapeutics Warrant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dermata Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dermata Therapeutics Warrant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dermata Stock Analysis

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.